The National Association of Chain Drug Stores delivered on Tuesday testimony on the safe usage of pediatric acetaminophen products before a joint meeting of the Food and Drug Administration Nonprescription Drugs Advisory Committee and Pediatric Advisory Committee.
A Food and Drug Administration panel will discuss findings in a clinical trial that has raised concerns about the safety and efficacy of Abbott's cholesterol-lowering drug when it’s combined with similar drugs, according to an FDA announcement.
CVS Caremark's MinuteClinic is looking to make it easier and more affordable for campers to get the physicals they need in order to participate in activities by offering discounts on camp and sports physicals through July 31.
The National Community Pharmacists Association on Tuesday endorsed the Community Pharmacy Fairness Act of 2011 (H.R. 1839), legislation recently introduced in the House of Representatives by Rep. Anthony Weiner, D-N.Y.
Nordic Naturals on Tuesday announced the company has earned certification from NSF International, verifying that its new Leadership in Energy and Environmental Design corporate headquarters complies with good manufacturing practices.
Perrigo on Monday announced that it has received final approval from the Food and Drug Administration for its abbreviated new drug application for over-the-counter ranitidine 150 (regular and cool mint), a generic version of Zantac 150.
An investigational drug made by InterMune improved breathing in patients with a rare and fatal lung disease, according to results of a late-stage clinical trial published online in The Lancet last week.
The American Pharmacists Association is marking Older Americans Month by urging seniors to increase their knowledge about medications and wellness by talking to their pharmacists, the group said Monday.
CVS Caremark announced on Monday that it will be launching a pilot of a real-time, integrated electronic prior authorization capability, available to its PBM clients, to help speed access to prescription medications.
The Food and Drug Administration is convening its Nonprescription Drugs Advisory Committee Tuesday and Wednesday to debate mandating weight-based dosing for pediatric medicines containing acetaminophen on the Drug Facts label, as well as the potential expansion of dosing instructions to incorporate children under the age of 2 years old, according to material posted online by the FDA on Friday.